Interim Order No. 2 Respecting Clinical Trials for Medical Devices and Drugs Relating to COVID-19
The Interim Order (IO) No. 2 continues to support the optional pathway introduced by IO No. 1 to facilitate clinical trials for potential COVID-19 drugs and medical devices.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2021-05-28
Data overview
- Formats
- HTML
- File languages
- English, French